Cargando…
A Novel DNA Repair Gene Signature for Immune Checkpoint Inhibitor-Based Therapy in Gastric Cancer
Gastric cancer is a heterogeneous group of diseases with only a fraction of patients responding to immunotherapy. The relationships between tumor DNA damage response, patient immune system and immunotherapy have recently attracted attention. Accumulating evidence suggests that DNA repair landscape i...
Autores principales: | Yuan, Binbin, Jiang, Chengfei, Chen, Lingyan, Wen, Lihui, Cui, Jinlong, Chen, Min, Zhang, Shu, Zhou, Lin, Cai, Yimeng, Mao, Jian-Hua, Zou, Xiaoping, Hang, Bo, Wang, Pin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168368/ https://www.ncbi.nlm.nih.gov/pubmed/35676932 http://dx.doi.org/10.3389/fcell.2022.893546 |
Ejemplares similares
-
A Genomic Signature Reflecting Fibroblast Infiltration Into Gastric Cancer Is Associated With Prognosis and Treatment Outcomes of Immune Checkpoint Inhibitors
por: Lu, Yi, et al.
Publicado: (2022) -
Identification of an Immune-Related LncRNA Signature in Gastric Cancer to Predict Survival and Response to Immune Checkpoint Inhibitors
por: Ding, Zuoyou, et al.
Publicado: (2021) -
TLRs as a Promise Target Along With Immune Checkpoint Against Gastric Cancer
por: Cui, Lin, et al.
Publicado: (2021) -
Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma
por: Chen, Zhuohui, et al.
Publicado: (2021) -
Identification of a novel 15‐gene expression signature predicting overall survival of human colorectal cancer
por: Jiang, Chengfei, et al.
Publicado: (2020)